Shaun is currently Head of Regulatory Affairs at ReNeuron PLC, a Wales based biotech company developing stem cell therapeutics.

He held positions of increasing responsibility in regulatory affairs at Sterling Winthrop, Eli Lilly, Boehringer Ingelheim and Ipsen, where he managed regulatory input into development programmes globally, securing new product approvals in the neurology, endocrinology and oncology therapeutic areas.

Shaun then spent 8 years in regulatory consultancy at RRG (Voisin Consulting Life Sciences) where he was a Director and Vice President of Regulatory Science. He supported clients on global development and registration projects, including extensive interaction with EU and US regulators.